WO2023061632A1 - Procédé mis en œuvre par ordinateur pour rassembler et stocker des données épidémiologiques pour calculer des paiements de dommages d'un fonds de propagateurs de maladies infectieuses - Google Patents
Procédé mis en œuvre par ordinateur pour rassembler et stocker des données épidémiologiques pour calculer des paiements de dommages d'un fonds de propagateurs de maladies infectieuses Download PDFInfo
- Publication number
- WO2023061632A1 WO2023061632A1 PCT/EP2022/070155 EP2022070155W WO2023061632A1 WO 2023061632 A1 WO2023061632 A1 WO 2023061632A1 EP 2022070155 W EP2022070155 W EP 2022070155W WO 2023061632 A1 WO2023061632 A1 WO 2023061632A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- computer
- implemented method
- spreaders
- payments
- disease
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 71
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 62
- 208000035473 Communicable disease Diseases 0.000 title abstract description 8
- 201000010099 disease Diseases 0.000 claims abstract description 98
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 98
- 238000002955 isolation Methods 0.000 claims abstract description 41
- 230000002458 infectious effect Effects 0.000 claims description 22
- 238000004364 calculation method Methods 0.000 claims description 19
- 241000700605 Viruses Species 0.000 claims description 7
- 230000036039 immunity Effects 0.000 claims description 4
- 230000000474 nursing effect Effects 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 3
- 238000003745 diagnosis Methods 0.000 claims description 3
- 230000028993 immune response Effects 0.000 claims description 2
- 230000003053 immunization Effects 0.000 claims description 2
- 230000009257 reactivity Effects 0.000 claims description 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 230000007480 spreading Effects 0.000 abstract description 4
- 208000025721 COVID-19 Diseases 0.000 description 13
- 230000034994 death Effects 0.000 description 13
- 231100000517 death Toxicity 0.000 description 13
- 241001678559 COVID-19 virus Species 0.000 description 7
- 238000013459 approach Methods 0.000 description 6
- 230000003993 interaction Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000002255 vaccination Methods 0.000 description 5
- 229960005486 vaccine Drugs 0.000 description 4
- 230000009133 cooperative interaction Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 2
- 208000031504 Asymptomatic Infections Diseases 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 208000005069 pulmonary fibrosis Diseases 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
- 229940026233 Pfizer-BioNTech COVID-19 vaccine Drugs 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000017188 evasion or tolerance of host immune response Effects 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000007482 viral spreading Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q40/00—Finance; Insurance; Tax strategies; Processing of corporate or income taxes
- G06Q40/08—Insurance
Definitions
- the SARS-CoV-2 virus is simultaneously: airborne highly contagious, produces a disease (covid19) severe enough to overwhelm health systems, has a short infectiousness interval that can be asymptomatic (pre-symptomatic, paucisymptomatic, or mild- symptomatic) (3)(4)(8), and hence classic Test/Trace/lsolate strategies are useless (i.e. infected do not report symptoms), or cannot be applied alone (i.e. imagine contagions in public night clubs), or it is impractical to determine individual infectiousness (e.g. daily PCR testing), and so the virus spreads without being traced.
- a computer for receiving, storing and processing data.
- a computer means an electronic device for storing and processing data, typically in binary form, according to instructions given to it in a variable program.
Landscapes
- Business, Economics & Management (AREA)
- Accounting & Taxation (AREA)
- Finance (AREA)
- Engineering & Computer Science (AREA)
- Development Economics (AREA)
- Economics (AREA)
- Marketing (AREA)
- Strategic Management (AREA)
- Technology Law (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
Abstract
Procédé mis en œuvre par ordinateur pour calculer des paiements de dommages causés par une maladie en raison d'une faute de propagateurs associés à une police d'assurance d'exemption d'isolement (IEIP). Sur la base d'une évaluation de dommages causés par une maladie attendus et de la faute partagée de victimes et de propagateurs de ne pas s'être isolés, des compagnies d'assurances s'accordent sur un procédé pour rassembler et stocker informatiquement des données épidémiologiques pour calculer des paiements versés au fonds de propagateurs et par celui-ci pour couvrir la part des dommages causés par une maladie subis par les victimes qui sont de la faute des propagateurs. Chaque fois qu'un emplacement subit une maladie infectieuse épidémique avec des contagions présymptomatiques significatives, et que des isolations obligatoires sont imposées à des individus asymptomatiques pour réduire la propagation, il pourrait être offert à ces individus une IEIP pour éviter ces isolations obligatoires. Le procédé mis en œuvre par ordinateur peut être mis à jour dans le temps. La partie des préjudices causés par une maladie qui est de la faute de la victime est couverte par chaque assureur.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202280066755.4A CN118215930A (zh) | 2021-10-11 | 2022-07-19 | 收集和存储流行病学数据以计算传染病传播基金的损害赔偿金的计算机实现的方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163254246P | 2021-10-11 | 2021-10-11 | |
| US63/254,246 | 2021-10-11 | ||
| US17/661,793 | 2022-05-03 | ||
| US17/661,793 US20230115691A1 (en) | 2021-10-11 | 2022-05-03 | Computer-implemented method to gather and store epidemiological data to calculate damages payments of an infectious disease spreaders fund |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2023061632A1 true WO2023061632A1 (fr) | 2023-04-20 |
Family
ID=82899200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2022/070155 WO2023061632A1 (fr) | 2021-10-11 | 2022-07-19 | Procédé mis en œuvre par ordinateur pour rassembler et stocker des données épidémiologiques pour calculer des paiements de dommages d'un fonds de propagateurs de maladies infectieuses |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2023061632A1 (fr) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7937279B2 (en) * | 2005-10-13 | 2011-05-03 | Bruce Bradford Thomas | Collateral damage limits |
| US8583458B2 (en) * | 2004-12-27 | 2013-11-12 | Swiss Reinsurance Company Ltd. | Dynamic system and method for automated checking and transmitting of damage reports and damage claims |
| US10949928B1 (en) | 2014-10-06 | 2021-03-16 | State Farm Mutual Automobile Insurance Company | System and method for obtaining and/or maintaining insurance coverage |
-
2022
- 2022-07-19 WO PCT/EP2022/070155 patent/WO2023061632A1/fr active Application Filing
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8583458B2 (en) * | 2004-12-27 | 2013-11-12 | Swiss Reinsurance Company Ltd. | Dynamic system and method for automated checking and transmitting of damage reports and damage claims |
| US7937279B2 (en) * | 2005-10-13 | 2011-05-03 | Bruce Bradford Thomas | Collateral damage limits |
| US10949928B1 (en) | 2014-10-06 | 2021-03-16 | State Farm Mutual Automobile Insurance Company | System and method for obtaining and/or maintaining insurance coverage |
Non-Patent Citations (17)
| Title |
|---|
| ESTUDIO NACIONAL DE SERO-EPIDEMIOLOGIA DE LA INFECCION POR SARS-COV-2 EN ESPANA, Retrieved from the Internet <URL:https://portalcne.isciii.es/enecovid19> |
| EXPLAINED: AUSTRIA'S NEW LAW THAT MAKES COVID-19 VACCINATION MANDATORY, Retrieved from the Internet <URL:https://indianexpress.com/article/explained/explained-austria-new-law-covid-19-vaccination-mandatory-7757973> |
| HAO-YUAN CHENG ET AL., CONTACT TRACING ASSESSMENT OF COVID-19 TRANSMISSION DYNAMICS IN TAIWAN AND RISK AT DIFFERENT EXPOSURE PERIODS BEFORE AND AFTER SYMPTOM ONSET, Retrieved from the Internet <URL:https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2765641> |
| HIAM CHEMAITELLY ET AL., WANING OF BNT162B2 VACCINE PROTECTION AGAINST SARS-COV-2 INFECTION IN QATAR, Retrieved from the Internet <URL:https://www.medrxiv.org/content/10.1101/2021.08.25.21262584v1.full> |
| LEVAN DJAPARIDZE, 2-STRATUM SEIRS MODEL, Retrieved from the Internet <URL:www.sars2seir.com/paper-10-2020> |
| LEVAN DJAPARIDZE, INFECTIOUS DISEASE SPREADERS FUND, Retrieved from the Internet <URL:www.sars2seir.com/patent> |
| LEVAN DJAPARIDZEFEDERICO LOIS, SARS-COV-2 WAVES IN EUROPE: A 2-STRATUM SEIRS MODEL SOLUTION, Retrieved from the Internet <URL:https://www.medrxiv.org/content/10.1101/2020.10.09.20210146v3> |
| MANDATORY VACCINATION AND THE FAILURE OF MODERN CONSTITUTIONAL LAW, Retrieved from the Internet <URL:https://libertarianinstitute.org/articles/mandatory-vaccination-and-the-failure-of-modern-constitutional-law> |
| NEIL FERGUSON ET AL., REPORT 49: GROWTH, POPULATION DISTRIBUTION AND IMMUNE ESCAPE OF OMICRON IN ENGLAND, Retrieved from the Internet <URL:https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2021-12-16-COVID19-Report-49.pdf> |
| NYC'S COVID-19 VACCINATION PROOF MANDATE FOR RESTAURANTS AND DINING: WHAT TO KNOW, Retrieved from the Internet <URL:https://www.wsj.com/articles/nycs-vaccination-proof-mandate-for-restaurants-and-dining-what-to-know-11631540546> |
| PANDEMIC RISK PROTECTION ACCELERATE RECOVERY AND BUILD RESILIENCE NOW THROUGH PUBLIC-PRIVATE PARTNERSHIP, June 2020 (2020-06-01), Retrieved from the Internet <URL:https://info.marsh.com/l/395202/2020-06-01/bmbxvj/395202/207425/pandemic_risk_protection_report.pdf> |
| PETR\^ONIO C L SILVA ET AL: "COVID-ABS: An Agent-Based Model of COVID-19 Epidemic to Simulate Health and Economic Effects of Social Distancing Interventions", ARXIV.ORG, CORNELL UNIVERSITY LIBRARY, 201 OLIN LIBRARY CORNELL UNIVERSITY ITHACA, NY 14853, 9 July 2020 (2020-07-09), XP081712189, DOI: 10.1016/J.CHAOS.2020.110088 * |
| ROMAN WOLFEL ET AL., VIROLOGICAL ASSESSMENT OF HOSPITALIZED PATIENTS WITH COVID-2019, Retrieved from the Internet <URL:https://www.nature.com/articles/s41586-020-2196-x> |
| SAHIN S ET AL: "COVID-19 in a social reinsurance framework: Forewarned is forearmed", ARXIV.ORG, CORNELL UNIVERSITY LIBRARY, 201 OLIN LIBRARY CORNELL UNIVERSITY ITHACA, NY 14853, 10 April 2020 (2020-04-10), XP081641686 * |
| SHIYI CAO ET AL., POST-LOCKDOWN SARS-COV-2 NUCLEIC ACID SCREENING IN NEARLY TEN MILLION RESIDENTS OF WUHAN, CHINA, Retrieved from the Internet <URL:https://www.nature.com/articles/s41467-020-19802-w> |
| SIVAN GAZIT ET AL., COMPARING SARS-COV-2 NATURAL IMMUNITY TO VACCINE-INDUCED IMMUNITY: REINFECTIONS VERSUS BREAKTHROUGH INFECTIONS, Retrieved from the Internet <URL:https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1> |
| VARDAVAS RAFFAELE ET AL: "The Health and Economic Impacts of Nonpharmaceutical Interventions to Address COVID-19 A Decision Support Tool for State and Local Policymakers", 1 May 2020 (2020-05-01), pages 1 - 94, XP055814867, Retrieved from the Internet <URL:https://www.rand.org/content/dam/rand/pubs/tools/TLA100/TLA173-1/RAND_TLA173-1.pdf> [retrieved on 20210617] * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Luce et al. | Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children | |
| Buttorff et al. | Economic evaluation of a task-shifting intervention for common mental disorders in India | |
| Mathu-Muju et al. | Oral health care for children in countries using dental therapists in public, school-based programs, contrasted with that of the United States, using dentists in a private practice model | |
| Tiruneh et al. | The effect of implementation strength of basic emergency obstetric and newborn care (BEmONC) on facility deliveries and the met need for BEmONC at the primary health care level in Ethiopia | |
| Huang et al. | Antibiotic prescribing by ambulatory care physicians for adults with nasopharyngitis, URIs, and acute bronchitis in Taiwan: a multi-level modeling approach | |
| Wanyonyi et al. | The relationship between access to and use of dental services following expansion of a primary care service to embrace dental team training | |
| Owens et al. | Designing a cost-effectiveness analysis | |
| Roxo‐Gonçalves et al. | EstomatoNet: A 5‐year experience of an oral medicine telediagnosis service | |
| US20230115691A1 (en) | Computer-implemented method to gather and store epidemiological data to calculate damages payments of an infectious disease spreaders fund | |
| WO2023061632A1 (fr) | Procédé mis en œuvre par ordinateur pour rassembler et stocker des données épidémiologiques pour calculer des paiements de dommages d'un fonds de propagateurs de maladies infectieuses | |
| Deeble | Resource allocation in public health: an economic approach | |
| Nikitin et al. | Cost-effectiveness of 4CMenB vaccination against gonorrhea: importance of dosing schedule, vaccine sentiment, targeting strategy, and duration of protection | |
| Slingsby et al. | Child health needs and the child abuse pediatrics workforce: 2020–2040 | |
| Molnar et al. | Public health impact of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among older adults in the United States | |
| Lovie-Toon et al. | The cost of acute respiratory infections with cough among urban Aboriginal and Torres Strait Islander children | |
| Bianchi et al. | Attitudes toward influenza vaccination in healthcare workers in Italy: A systematic review and meta-analysis | |
| Nanuli et al. | GENDER BUDGETING IN THE FIELD OF GEORGIAN HEALTH AND SOCIAL PROTECTION: ANALYSIS AND EVALUATION | |
| Newall et al. | Economic report into the cost of influenza to the Australian Health System | |
| Moek et al. | Trends in age-specific varicella incidences following the introduction of the general recommendation for varicella immunization in Germany, 2006–2022 | |
| Novaes et al. | Impacts of the COVID-19 pandemic on immunization with pneumococcal vaccines in children and older adults in Brazil | |
| Carmel et al. | Social class differences in coping with a physicians' strike in Israel | |
| CN118215930A (zh) | 收集和存储流行病学数据以计算传染病传播基金的损害赔偿金的计算机实现的方法 | |
| Ejigu et al. | Medication adherence and associated factors among patients on highly active antiretroviral therapy in Nekemte Hospital, Ethiopia: Etiyopya’daki Nekemte Hastanesi’nde yüksek oranda aktif antiretroviral tedavi alan hastalardaki tedaviye uyum ve ilişkili faktörler | |
| Jahnz-Różyk et al. | Primary immunodeficiencies–epidemiology, spending on therapy, diagnostic and therapeutic needs in Poland | |
| Kazungu | Cost structure of healthcare in Kaloleni Subcounty (Kilifi, Kenya) from the patient perspective: Measuring the impact of direct healthcare costs on patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22754355 Country of ref document: EP Kind code of ref document: A1 |
|
| REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112024004995 Country of ref document: BR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2022754355 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2022754355 Country of ref document: EP Effective date: 20240513 |
|
| ENP | Entry into the national phase |
Ref document number: 112024004995 Country of ref document: BR Kind code of ref document: A2 Effective date: 20240314 |